Not Intended for Therapeutic Use. For research use only.

Brevetoxin PbTx-3 - CAS 85079-48-7

Quick Inquiry

Name:
* Email:
* Service & Products of Interest:
* Quantity:
* Verification code:
Please input "bocsci" as verification code.
Category
ADCs
Product Name
Brevetoxin PbTx-3
Catalog Number
85079-48-7
CAS Number
85079-48-7
Description
An activator of voltage-sensitive Na+ channels, a suite of cyclic polyether compounds produced naturally by a species of dinoflagellate known as Karenia brevis. A ciguatoxin comprising a linear sequence of ten trans-fused five-, six-, eight- and nine-membered rings.
Molecular Weight
897.11
Molecular Formula
C50H72O14
COA
Inquire
MSDS
Inquire
Tag
ADCs Cytotoxin
Structure
CAS 85079-48-7 Brevetoxin PbTx-3
Specification
Purity
95 % (HPLC).
Melting Point
291-293 °C. (decomp.)
Appearance
Solid powder
Application
ADCs Cytotoxin
Storage
Brevetoxins are unusually stable materials in the dry state under vacuum.
Solubility
acetone, ethyl acetate, methanol, ethanol, water.
Related ADCs Cytotoxin Products
  • Adaphotris
    (CAS: )

    Inhibitor of Ca2+/2H+-exchange system in liver mitochondria. , synthetic.

  • KALIOTOXIN (1-37)NH2
    (CAS: )

    Kaliotoxin (1-37)NH2 is a selective voltage-dependent K+ channels blocker, a blocker of Ca2+-activated K+ channels of high conductance and some voltage-dependen...

  • CAS 31329-58-5 Veratroylzygadenine

    Veratroylzygadenine
    (CAS: 31329-58-5)

    An analog of Veratridine; Na+ channel activator; potent neurotoxic; depolarizing agent on membranes of nerve terminal, muscle and gland cells.

  • CAS 107265-50-9 KYuR-14 HCl

    KYuR-14 HCl
    (CAS: 107265-50-9)

    A cytostatic substance Isotryptamine.

  • Bj-xtrlT (recombinant)
    (CAS: )

    An excitatory scorpion toxin. Polypeptide, of 77 amino acids cross-linked by 4 disulfide bridges. Recombinant toxin produced in<br/>Escherichia coli initialy fr...

  • CAS 35846-53-8 Maytansine

    Maytansine
    (CAS: 35846-53-8)

    Maitansine, a cytotoxic agent, inhibits the assembly of microtubules by binding to tubulin at the rhizoxin binding site.

  • DM4
    (CAS: 796073-69-3)

    DM 4 is an intermediate used to prepare semisynthetic maytansine analogs which can be conjugated with antibodies for the targeted treatment of cancer.

  • CAS 22352-41-6 Hippeastrine hydrobromide

    Hippeastrine hydrobromide
    (CAS: 22352-41-6)

    Amaryllidaceae alkaloid from plants of the Amaryllidaceae family. A hypotensive, sedative. Amaryllidaceae alkaloid , from plants of the Amaryllidaceae family.

  • (-)-Scopolamine Perchlorate
    (CAS: )

    Scopolamine, a nonselective muscarinic receptor antagonist, induces distinct behaviors of attenuated motility and C-like hyperactivity.

  • CAS 24345-16-2 Apamin

    Apamin
    (CAS: 24345-16-2)

    Apamin is an 18 amino acid peptide toxin found in bee venom. Apamin is used to elucidate the roles of these channels in cells and tissues expressing SK channels...

  • CAS 23214-92-8 Doxorubicin

    Doxorubicin
    (CAS: 23214-92-8)

    Doxorubicin(Adriamycin) is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis.

  • CAS 203849-91-6 MMAD

    MMAD
    (CAS: 203849-91-6)

    Monomethyl auristatin D (MMAD), a potent tubulin inhibitor, is a toxin payload and antibody drug conjugate.

  • CAS 112300-33-1 Ethoquine

    Ethoquine
    (CAS: 112300-33-1)

    AChR agonist. Rigid bicyclic analog of ACh and ARECOLINE. Good penetration of biological membranes. Quinuclidine derivative, , synthetic.

  • CAS 118-08-1 Beta-(-)-Hydrastine

    Beta-(-)-Hydrastine
    (CAS: 118-08-1)

    Hydrastine is a natural alkaloid which is present in Hydrastis canadensis and other plants of the ranunculaceae family.

  • CAS 52358-55-1 Delcorine

    Delcorine
    (CAS: 52358-55-1)

    Antiarrhythmic and hypotensive; ganglion blocker; exhibits weak affinity at brain α-bungarotoxin-sensitive nicotinic acetylcholine receptors.

  • CAS 20830-81-3 Daunorubicin

    Daunorubicin
    (CAS: 20830-81-3)

    Daunorubicin(RP13057) inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM.

  • CAS 95506-56-2 Fasciculin 2

    Fasciculin 2
    (CAS: 95506-56-2)

    Potent, reversible acetylcholinesterase inhibitor

  • CAS 4368-28-9 Tetrodotoxin

    Tetrodotoxin
    (CAS: 4368-28-9)

    TTX is a potent marine-derived neurotoxin that reversibly inhibits the inward sodium current through voltage-activated sodium (NaV) channels, blocking nerve and...

  • LK-66 M
    (CAS: )

    A muscarinic receptors antagonist.

  • CAS 33069-62-4 Paclitaxel

    Paclitaxel
    (CAS: 33069-62-4)

    Paclitaxel is a microtubule polymer stabilizer with IC50 of 0.1 pM in human endothelial cells.

Reference Reading
1.Inhalation toxicity of brevetoxin 3 in rats exposed for twenty-two days.
Benson JM1, Hahn FF, March TH, McDonald JD, Gomez AP, Sopori MJ, Bourdelais AJ, Naar J, Zaias J, Bossart GD, Baden DG. Environ Health Perspect. 2005 May;113(5):626-31.
Brevetoxins are potent neurotoxins produced by the marine dinoflagellate Karenia brevis. Exposure to brevetoxins may occur during a K. brevis red tide when the compounds become aerosolized by wind and surf. This study assessed possible adverse health effects associated with inhalation exposure to brevetoxin 3, one of the major brevetoxins produced by K. brevis and present in aerosols collected along beaches affected by red tide. Male F344 rats were exposed to brevetoxin 3 at 0, 37, and 237 microg/m3 by nose-only inhalation 2 hr/day, 5 days/week for up to 22 exposure days. Estimated deposited brevetoxin 3 doses were 0.9 and 5.8 microg/kg/day for the low- and high-dose groups, respectively. Body weights of the high-dose group were significantly below control values. There were no clinical signs of toxicity. Terminal body weights of both low- and high-dose-group rats were significantly below control values. Minimal alveolar macrophage hyperplasia was observed in three of six and six of six of the low- and high-dose groups, respectively.
2.Distribution of Brevetoxin to Lipoproteins in human plasma.
Woofter RT1, Ramsdell JS. Toxicon. 2007 Jun 1;49(7):1010-8. Epub 2007 Feb 8.
To better understand the distribution of brevetoxins in lipoproteins, including their role in tissue delivery and toxin elimination in humans, we examined the interaction of brevetoxin congener PbTx-3 with human lipoproteins. In a scintillation proximity assay (SPA) and microtiter equilibrium dialysis, brevetoxin bound linearly to purified human high density, low density, and very low density lipoproteins (HDL, LDL, and VLDL). Both methods demonstrated higher binding capacity per weight for HDL over the other lipoproteins; approximately 50% higher with SPA and 100% higher with equilibrium dialysis. The preferential binding of brevetoxin to HDL particles is consistent with the higher surface to volume ratio of these particles and the association of the toxin with the surface phospholipid/cholesterol domain of the lipoprotein particle. Lipoprotein components were next separated from a well-characterized human plasma sample to determine the mass distribution of brevetoxin within plasma.
3.Effects of a red-tide toxin on fish hearing.
Lu Z1, Tomchik SM. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2002 Nov;188(10):807-13. Epub 2002 Nov 13.
Red tides are formed from blooms of marine algae. Among them, the dinoflagellate ( Karenia brevis) that is responsible for Florida red tides can release many types of natural toxins, which cause massive kills of marine animals, including endangered species, and threaten human health. This study was to investigate whether or not a neurotoxin, brevetoxin-3, purified from Florida red tides affects hearing sensitivity of a teleost fish, the goldfish ( Carassius auratus). LD(50) of the goldfish that were intraperitoneally injected with brevetoxin-3 was 0.068 microg g(-1). Evoked auditory brainstem responses were recorded, and hearing threshold was determined using a correlation method. By comparing thresholds of fish before and after a sublethal-dose injection (0.064 microg g(-1)) of the toxin, we found that brevetoxin-3 significantly reduces auditory sensitivity up to 9 dB at low frequencies (100 Hz and 500 Hz), but not at a high frequency (2,000 Hz).
4.Identification of a rapid detoxification mechanism for brevetoxin in rats.
Radwan FF1, Wang Z, Ramsdell JS. Toxicol Sci. 2005 Jun;85(2):839-46. Epub 2005 Mar 2.
We examined detoxification of brevetoxin in rats through metabolic activities and key elimination routes by analyzing samples from individual rats exposed to two brevetoxin congeners (PbTx-2 and PbTx-3). Brevetoxins were detected by radioimmunoassay in methanolic extracts of blood within 1 h post intraperitoneal (ip) administration. The toxin assay response was about three times higher in PbTx-2-treated rats versus the same dose (180 microg/kg) of PbTx-3. This difference persisted for up to 8 h postexposure. When the blood samples were reextracted with 20% methanol to enhance recovery of potential polar brevetoxin metabolites, 25-fold higher assay activity was present in the PbTx-2-treated rats. Analysis of urine from the same animals identified 7-fold more activity in the PbTx-2-treated rats that accumulated over the course of 24 h. Radioimmunoassay-guided high performance liquid chromatographic analysis of urine from PbTx-2-treated rats yielded three major peaks of activity.
2005 - BOC Sciences | All rights reserved
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
BOCSciences
X CLOSE
DOWNLOAD